We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $542M
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+18.94%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$331M
AUM Growth
+$70.7M
Cap. Flow
+$40.7M
Cap. Flow %
12.27%
Top 10 Hldgs %
51.22%
Holding
94
New
25
Increased
23
Reduced
17
Closed
17

Top Buys

Rank Stock Value
1
TREE icon
LendingTree
TREE
+$7.19M
2
STNE icon
StoneCo
STNE
+$6.55M
3
FATE icon
Fate Therapeutics
FATE
+$4.7M
4
TSP
TuSimple Holdings Inc. Class A Common Stock
TSP
+$4.15M
5
BMO icon
Bank of Montreal
BMO
+$4.14M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$7.99M
2
AA icon
Alcoa
AA
+$4.57M
3
B
Barrick Mining
B
+$3.98M
4
GSK icon
GSK
GSK
+$3.1M
5
NOV icon
NOV
NOV
+$2.73M

Sector Composition

Rank Sector Weight
1 Energy 20.1%
2 Healthcare 16.59%
3 Materials 9.45%
4 Technology 5.81%
5 Financials 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAOI icon
51
Applied Optoelectronics
AAOI
$7.59B
$990K 0.3%
523,867
+153,867
+42% +$366K
LUMN icon
52
Lumen
LUMN
$6.7B
$914K 0.28%
+175,000
New +$1.08M
OLMA icon
53
Olema Pharmaceuticals
OLMA
$1.02B
$861K 0.26%
351,517
+166,246
+90% +$485K
ALCO icon
54
Alico
ALCO
$282M
$840K 0.25%
35,176
-11,521
-25% -$333K
LKFT
55
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.79B
$829K 0.25%
18,678
+8,678
+87% +$365K
TLRY icon
56
Tilray
TLRY
$595M
$740K 0.22%
+27,500
New +$963K
IOVA icon
57
Iovance Biotherapeutics
IOVA
$1.9B
$735K 0.22%
+115,000
New +$898K
TEVA icon
58
Teva Pharmaceuticals
TEVA
$40.4B
$684K 0.21%
75,000
-59,000
-44% -$515K
CMRC
59
Commerce.com Inc Series 1
CMRC
$256M
$656K 0.2%
+75,000
New +$813K
PRQR icon
60
ProQR Therapeutics
PRQR
$244M
$611K 0.18%
165,000
-766,400
-82% -$1M
DNOW icon
61
DNOW Inc
DNOW
$2.54B
$580K 0.18%
45,672
– –
CGC
62
Canopy Growth
CGC
$381M
$578K 0.17%
+25,000
New +$771K
VTRS icon
63
CALL
Viatris
VTRS
$20.4B
$569K 0.17%
51,100
– –
CCJ icon
64
Cameco
CCJ
$37B
$567K 0.17%
+25,000
New +$588K
VNTR
65
DELISTED
Venator Materials PLC
VNTR
$510K 0.15%
945,476
-255,528
-21% -$178K
MRTX
66
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$452K 0.14%
9,985
-7,015
-41% -$454K
BTG icon
67
B2Gold
BTG
$5B
$419K 0.13%
117,365
– –
SOL
68
DELISTED
Emeren Group
SOL
$407K 0.12%
+90,000
New +$416K
ADVM
69
DELISTED
Adverum Biotechnologies
ADVM
$382K 0.12%
65,958
+43,458
+193% +$330K
BLUE
70
DELISTED
bluebird bio
BLUE
$346K 0.1%
2,500
-1,500
-38% -$211K
FVRR icon
71
Fiverr
FVRR
$327M
$291K 0.09%
+10,000
New +$314K
SWBI icon
72
Smith & Wesson
SWBI
$653M
$260K 0.08%
+30,000
New +$316K
AA icon
73
Alcoa
AA
$12B
$227K 0.07%
5,000
-105,000
-95% -$4.57M
NGD
74
DELISTED
New Gold Inc
NGD
$136K 0.04%
138,837
– –
ISO
75
DELISTED
IsoPlexis Corporation Common Stock
ISO
$132K 0.04%
+85,000
New +$128K
1 2
3
4

Similar funds

BCB
Brian C. Broderick $542M AUM 20.28% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
MCM
Mitchell Capital Management Leawood, Kansas $545M AUM 46.33% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $545M AUM 18.58% 1-Year Est. Return

Monaco Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Monaco Asset Management held 94 positions worth $331M, up 27% from $261M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Monaco Asset Management deployed $40.7M of net new capital in Q4 2022, opening 25 new positions and adding to 23 existing holdings. Its largest new stake was Fate Therapeutics: 250,000 shares worth $2.52M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Viatris, an estimated $7.99M trimmed.

  • Monaco Asset Management's largest Q4 2022 buy was Fate Therapeutics: 250,000 shares worth $2.52M.
  • Monaco Asset Management added most to LendingTree in Q4 2022, an estimated $7.19M increase.
  • Monaco Asset Management's biggest Q4 2022 reduction was Viatris, cutting an estimated $7.99M.
  • Monaco Asset Management fully exited GSK in Q4 2022, selling an estimated $3.1M.
  • Monaco Asset Management's ten largest holdings make up 51% of its $331M portfolio in Q4 2022.
  • Monaco Asset Management opened 25 new positions and closed 17 in Q4 2022.
  • Monaco Asset Management's portfolio value rose 27% quarter-over-quarter to $331M.

Based on Monaco Asset Management's 13F filing for Q4 2022, filed 31 Jan 2023.